These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33203873)

  • 1. The use of prostate specific antigen density to predict clinically significant prostate cancer.
    Yusim I; Krenawi M; Mazor E; Novack V; Mabjeesh NJ
    Sci Rep; 2020 Nov; 10(1):20015. PubMed ID: 33203873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
    Janane A; Hajji F; Ismail T; Jawad C; Elondo JC; Dakka Y; Ghadouane M; Ameur A; Abbar M; Albouzidi A
    Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
    Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml
    Wang C; Wang YY; Wang SY; Ding JX; Ding M; Ruan Y; Wang XH; Jing YF; Han BM; Xia SJ; Jiang CY; Zhao FJ
    Asian J Androl; 2021; 23(4):415-420. PubMed ID: 33473011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men.
    Teoh JY; Yuen SK; Tsu JH; Wong CK; Ho BS; Ng AT; Ma WK; Ho KL; Yiu MK
    Asian J Androl; 2017; 19(1):113-116. PubMed ID: 26620456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
    MacAskill F; Lee SM; Eldred-Evans D; Wulaningsih W; Popert R; Wolfe K; Van Hemelrijck M; Rottenberg G; Liyanage SH; Acher P
    Int Urol Nephrol; 2017 Aug; 49(8):1335-1342. PubMed ID: 28477301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort.
    Washington SL; Baskin AS; Ameli N; Nguyen HG; Westphalen AC; Shinohara K; Carroll PR
    AJR Am J Roentgenol; 2020 Mar; 214(3):574-578. PubMed ID: 31913068
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    Int J Urol; 2005 Oct; 12(10):881-5. PubMed ID: 16323981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?
    Ohori M; Dunn JK; Scardino PT
    Urology; 1995 Nov; 46(5):666-71. PubMed ID: 7495118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer].
    Martínez Jabaloyas JM; García Morata F; Villamón Fort R; Pastor Hernández F; Gil Salom M; García Sisamón F
    Actas Urol Esp; 2003 Jun; 27(6):442-9. PubMed ID: 12918151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml.
    Akdas A; Tarcan T; Türkeri L; Cevik I; Biren T; Ilker Y
    Eur Urol; 1996; 29(2):189-92. PubMed ID: 8647145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
    Bretton PR; Evans WP; Borden JD; Castellanos RD
    Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective evaluation of PSA density for selection of biopsy candidates with prostate specific antigen in the gray zone].
    Tochigi T; Kawamura S; Numahata K; Tokuyama S; Kuwahara M; Horaguchi T; Satou S
    Nihon Hinyokika Gakkai Zasshi; 2001 Sep; 92(6):609-14. PubMed ID: 11593702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project.
    Littrup PJ; Kane RA; Mettlin CJ; Murphy GP; Lee F; Toi A; Badalament R; Babaian R
    Cancer; 1994 Dec; 74(12):3146-58. PubMed ID: 7526969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.
    Schmid HP; Ravery V; Billebaud T; Toublanc M; Boccon-Gibod LA; Hermieu JF; Delmas V; Boccon-Gibod L
    Urology; 1996 May; 47(5):699-703. PubMed ID: 8650868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density.
    Benson MC; McMahon DJ; Cooner WH; Olsson CA
    World J Urol; 1993; 11(4):206-13. PubMed ID: 7508785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
    Sheikh M; Al-Saeed O; Kehinde EO; Sinan T; Anim JT; Ali Y
    Int Urol Nephrol; 2005; 37(4):721-6. PubMed ID: 16362587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.